LANCASTER Skin Perfect Radical Dark Spots Correcting Serum, 30ml (1oz)

Description

Reduce the appearance of dark spots by up to -75%(1) and reveal a brighter, more even-looking complexion with Lancaster Skin Perfect Radical Dark Spots Correcting Serum.

Daily UV exposure is a leading cause of hyperpigmentation and visible dark spots. Lancaster developed its most advanced dark spot correction technology to date to target the appearance of different types of hyperpigmentation.

Powered by breakthrough, patent-pending CHROMA-5X™ Technology, this advanced dark spot serum targets 5 types of dark spots:

• Sun spots

• Age spots

• Acne marks

• Melasma

• Post-inflammatory marks

Its formula is concentrated with over 14% highly effective actives(3), including Tranexamic Acid, Salvianolic Acid, 5% Niacinamide, Phenylethyl Resorcinol, Red Algae Extract and Bisabolol.

Together, they help visibly reduce the appearance of dark spots and reveal clearer, brighter and more even-looking skin.

CHROMA-5X™ Technology is scientifically demonstrated to be as effective as hydroquinone 2% in an ex vivo test(4), while offering excellent skin tolerance.

The lightweight, silky serum texture is suitable for all skin types and skin tones. It absorbs instantly and leaves skin with a non-greasy, non-sticky finish, making it easy to layer into any skincare routine.

Clinical results:

• Up to -75% dark spots(1)

• Up to -50% sun spots(5)

• Up to -34% age spots(6)

• Up to -75% acne marks(7)

• Up to -50% melasma(8)

• Up to -75% other post-inflammatory marks(9)

• +52% skin brightness(2)

Clinical tests:

(1) Clinical test on 49 women, two applications per day for 12 weeks, top 10% on skin marks.

(2) Clinical test on 79 women, two applications per day for 12 weeks.

(3) PCT/US2025/058611.

(4) Ex vivo test on technology vs. Hydroquinone 2%.

(5) Clinical test on 48 women, two applications per day during 12 weeks, top responders.

(6) Clinical test on 38 women, two applications per day during 12 weeks, top responders.

(7) Clinical test on 29 women, two applications per day during 12 weeks, top responders.

(8) Clinical test on 36 women, two applications per day during 12 weeks, top responders.

(9) Clinical test on 31 women, two applications per day during 12 weeks, top responders.